Cell-based Assay Market by Offerings, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

List of Tables

The Global Cell-based Assay Market is forecasted to grow significantly, with a projected USD 16.63 billion in 2023 at a CAGR of 7.42% and expected to reach a staggering USD 27.50 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell-based Assay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell-based Assay Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents. The Instruments is projected to witness significant market share during forecast period.

Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies. The Drug Discovery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Academic & Government Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell-based Assay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell-based Assay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell-based Assay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell-based Assay Market?

4. What is the competitive strategic window for opportunities in the Global Cell-based Assay Market?

5. What are the technology trends and regulatory frameworks in the Global Cell-based Assay Market?

6. What is the market share of the leading vendors in the Global Cell-based Assay Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell-based Assay Market?

Product Code: MRR-436B79517C47

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cell-based Assay Market, by Offerings, 2022 vs 2030
4.3. Cell-based Assay Market, by Application, 2022 vs 2030
4.4. Cell-based Assay Market, by End-User, 2022 vs 2030
4.5. Cell-based Assay Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
  - 5.1.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
  - 5.1.1.3. Rising worldwide demand for novel drugs and treatments
- 5.1.2. Restraints
  - 5.1.2.1. Limited skilled professionals
- 5.1.3. Opportunities
  - 5.1.3.1. Rising use of cell-based assays in various ultra-high throughput screening
  - 5.1.3.2. Growing number of in-vitro drug studies based on cell-based assays
- 5.1.4. Challenges
  - 5.1.4.1. Unfavorable regulatory framework
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Cell-based Assay Market, by Offerings

6.1. Introduction
6.2. Consumables
- 6.2.1. Assay Kits
- 6.2.2. Cell Lines
- 6.2.3. Microplates
- 6.2.4. Probes & Labels
- 6.2.5. Reagents
6.3. Instruments
6.4. Services

7. Cell-based Assay Market, by Application

7.1. Introduction
7.2. Basic Research
7.3. Drug Discovery
- 7.3.1. Pharmacodynamic Studies
- 7.3.2. Pharmacokinetic Studies
- 7.3.3. Toxicity Studies

8. Cell-based Assay Market, by End-User

8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Cell-based Assay Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cell-based Assay Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cell-based Assay Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing